4 Results for "

Sangivamycin

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Sangivamycin" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-118384
CAS No.: 18417-89-5
Purity:  97.68%
Synonyms: NSC 65346; BA-90912
Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141687
CAS No.: 22242-89-3
Purity:  99.97%
Target:  

CDK Apoptosis

Research Areas:  

Cancer

NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors .
loading...
    loading...
Cat. No.: HY-118384R
CAS No.: 18417-89-5
Synonyms: NSC 65346 (Standard); BA-90912 (Standard)
Sangivamycin (Standard) is the analytical standard of Sangivamycin. This product is intended for research and analytical applications. Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers[1][2].
loading...
    loading...
Cat. No.: HY-136841
CAS No.: 22242-91-7
Target:  

CDK

Research Areas:  

Cancer

SLM6 is a sangivamycin-like molecule. SLM6 is a CDK9 inhibitor. SLM6 inhibits CDK9/cyclin K and CDK9/cyclin T1 kinase activity with IC50s of 280 nM and 133 nM, respectively. SLM6 also inhibits CDK1/cyclin B and CDK2/ cyclin A with IC50s of less than 300 nM. SLM6 induces apoptosis in multiple myeloma (MM) cells .
loading...
    loading...